V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors

O M Grbovic1, A D Basso, A Sawai

  • 1Program in Molecular Pharmacology and Chemistry and Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Insights

Heat shock protein 90 (Hsp90) is crucial for the stability of mutated B-Raf in melanoma. Inhibiting Hsp90 degrades mutant B-Raf, offering a potential therapeutic strategy for melanoma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The Raf family kinases, including B-Raf, are critical regulators of cell signaling.
  • B-Raf mutations are prevalent in melanoma and other cancers, driving tumor growth.
  • Heat shock protein 90 (Hsp90) is a molecular chaperone involved in protein folding and stability.

Purpose of the Study:

  • To investigate the role of Hsp90 in the stability and function of Raf kinases, particularly mutated B-Raf.
  • To evaluate the therapeutic potential of Hsp90 inhibition in melanoma models.

Main Methods:

  • Assessing the Hsp90 dependence of Raf-1, A-Raf, and B-Raf isoforms.
  • Analyzing the interaction of mutated B-Raf with the Hsp90-cdc37 complex.
  • Treating melanoma cells and tumors with the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
  • Measuring B-Raf degradation, mitogen-activated protein kinase (MAPK) activation, cell proliferation, apoptosis, and antitumor activity.

Main Results:

  • Raf-1 and A-Raf require Hsp90 for stability, while wild-type B-Raf does not.
  • Mutated, activated B-Raf binds to the Hsp90-cdc37 complex, which is essential for its stability and function.
  • Hsp90 inhibition leads to degradation of mutant B-Raf, suppressed MAPK signaling, reduced cell proliferation, and induced apoptosis.
  • Treatment with an Hsp90 inhibitor demonstrated significant antitumor activity in melanoma models.

Conclusions:

  • Activated, mutated B-Raf proteins are dependent on Hsp90 for proper folding and stability.
  • Hsp90 plays a critical role in the clonal evolution of melanomas dependent on B-Raf mutations.
  • Hsp90 inhibition is a promising therapeutic strategy for treating melanoma and other B-Raf-driven tumors.

Related Concept Videos

Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...